Shi, Hao http://orcid.org/0000-0002-2796-629X
Doench, John G. http://orcid.org/0000-0002-3707-9889
Chi, Hongbo http://orcid.org/0000-0002-9997-2496
Article History
Accepted: 4 November 2022
First Online: 8 December 2022
Competing interests
: J.G.D. consults for Microsoft Research, Abata Therapeutics, Servier, Maze Therapeutics, BioNTech, Sangamo and Pfizer; consults for and has equity in Tango Therapeutics; serves as a paid scientific adviser to the Laboratory for Genomics Research, funded in part by GlaxoSmithKline; and receives funding support from the Functional Genomics Consortium: Abbvie, Bristol Myers Squibb, Janssen, Merck and Vir Biotechnology. Interests of J.G.D. were reviewed and are managed by the Broad Institute in accordance with its conflict of interest policies. H.C. consults for Kumquat Biosciences. H.S. declares no competing interests.